Millie
your market intelligence analyst
Search Results
138 results
Your search is now limited to «Kidney Cancer» expert search.
FeedNavigator (EU) 08/04/2020 09:21
Associating cancer, kidney disease, and stroke with COVID-19 severity should be carefully interpreted.
More from FeedNavigator (EU):
Business Wire 08/04/2020 07:00
This TCR therapy is currently in a Phase 1 trial at NHLBI for the treatment of metastatic clear cell Renal Cell Carcinoma (ccRCC) that failed an angiogenic inhibitor and a checkpoint inhibitor.
More from Business Wire:
San Diego, CA Alterations of the Hippo signaling pathway have been found in patients with sarcomatoid renal cell carcinoma, a highly aggressive kidney disease with rapid progression and poor prognosis.
More from Molecular Cancer Research - Recent Issues (abstracts):
PubMed News (NIH) 08/01/2020
By performing transcriptomics analyses from TRACK versus wild type (WT) kidneys after dietary vitamin A deprivation, we show that both vitamin A deficiency (VAD) and expression of constitutively active HIF1α intensify the MSR, redirect amino acids to one carbon metabolism, and facilitate the biosynthesis of reduced ...
More from PubMed News (NIH):
ClinicalTrials.gov 07/31/2020 07:58
Evidence indicates to worse outcomes in patients with pre-existing diseases, such as diabetes, arterial hypertension, heart disease, pneumopathies, chronic kidney disease, and immunodeficiencies.
More from ClinicalTrials.gov:
PharmiWeb.com 07/31/2020 05:11
Professor Amit Bahl, a consultant medical oncologist specialised in renal cell carcinoma, said: “This positive recommendation from NICE provides patients with advanced Renal Cancer an effective and well tolerated treatment option with proven benefits in progression free survival and objective response rates from a randomised Phase 3 ...
PharmaTimes 07/31/2020 02:50
This positive recommendation from NICE provides patients with advanced renal cancer an effective and well tolerated treatment option with proven benefits in progression free survival and objective response rates from a randomised Phase III trial,” said Professor Amit Bahl, a consultant medical oncologist specialised in renal ...
Healio News 07/29/2020 11:09
Inactivation of von-Hippel-Lindau occurs in more than 90% of clear cell renal cell carcinoma tumors.
More from Healio News:
Registrations of Patients with Renal Cell Carcinoma in the Nationwide Danish Renal Cancer Database versus the Danish Cancer Registry: Data Quality, Completeness and Survival (DaRenCa Study-3)
More from International Journal of COPD:
Cancer Cell International 07/23/2020 20:00
The fluorescence signal intensity in the renal region of nude mice was measured weekly by in vivo optical imaging system (IVIS Spectrum, Caliper, USA) [16.
More from Cancer Cell International:
News-Medical.net 07/22/2020 20:41
Experts use genomic analysis tools to create personalized treatment for kidney cancer patients.
More from News-Medical.net:
Purpose:. Translocation renal cell carcinoma (tRCC) is a rare, aggressive renal cell carcinoma (RCC) subtype. There is currently limited understanding on the role of molecular alterations in the pathogenesis and progression of these tumors. We investigated the association between somatic alterations and clinical outcomes in two independent cohorts profiled using DNA sequencing. Experimental Design:. Twenty-two tRCCs underwent targeted sequencing [Memorial Sloan Kettering Cancer Center (MSK)-IMPACT]; a subset was profiled using exome-sequencing and combined with exome data from The Cancer Genome Atlas (TCGA) for analysis. The prognostic value of specific somatic aberrations, tumor mutation burden (TMB), and fraction of copy-number–altered geno.
More from Clinical Cancer Research - Recent Issues (abstracts):
Importantly, Rac1 controls paracrine signaling of angiogenic factors including VEGF from renal carcinoma cells to surrounding blood vessels.
More from Molecular Cancer Therapeutics - Recent Issues (abstracts):
We compared the prevalence and adjusted prevalence ratios (aPR) of cigarette smoking (current vs. never, former vs. never) among individuals diagnosed between 2011 and 2016 with clear cell RCC, papillary RCC, chromophobe RCC, renal collecting duct/medullary carcinoma, cyst-associated RCC, and unclassified RCC.
More from Cancer Epidemiology, Biomarkers & Prevention Recent Issues (abstracts):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications